Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TSX/MBX stock hub

TSX/MBX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TSX/MBXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
34.5M
Toronto Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TSX/MBX
In the news

Latest news · TSX/MBX

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11P50 15.6P75 25.4
Trailing P/En/a
P25 7.4P50 15.6P75 34.3
ROE-15.4
P25 -121.5P50 -40.9P75 0.5
ROIC-15.4
P25 -72.5P50 -16P75 1.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TSX/MBX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
189
Groups with data
11
Currency
CAD
Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Canada
Country code
CA
Employees
70
Enterprise value
CAD 32.3M
Exchange
Toronto Stock Exchange
Financial currency
CAD
First seen
2026-05-10
Industry
Biotechnology
Isin
CA59501P1045
Last refreshed
2026-05-10
Market cap
CAD 34.5M
Price
CAD 0.25
Price currency
CAD
Rev Per Employee
167,602.73x
Sector
Healthcare
Sic
2836
Symbol
tsx/MBX
Website
https://www.microbix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-12.37%
EV Earnings
-7.56x
EV/FCF
-7.61x
EV/Sales
1.93x
FCF yield
-12.29%
P/B ratio
1.3x
P/S ratio
2.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
-21.49%
EBITDA Margin
-13.39%
Gross margin
46.74%
Gross Profit
CAD 7.8M
Gross Profit Growth
-39.37%
Gross Profit Growth Q
-53.81%
Gross Profit Growth3 Y
-4.83%
Gross Profit Growth5 Y
7.87%
Net Income
CAD -4.3M
Net Income Growth Years
0%
Pretax Margin
-25.81%
Profit Margin
-25.48%
Profit Per Employee
CAD -42,700
ROA
-5.93
Roa5y
3.58
ROCE
-10.75
ROE
-15.39
Roe5y
7.81
ROIC
-15.39
Roic5y
8.87

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

12
MetricValue
Cagr10y
-0.58%
Cagr15y
-2.22%
Cagr1y
-34.23%
Cagr20y
-5.28%
Cagr3y
-13.02%
Cagr5y
-16.06%
EPS Growth Years
0
Revenue Growth
-27.23x
Revenue Growth Q
-30.2x
Revenue Growth Years
0x
Revenue Growth3 Y
0.07x
Revenue Growth5 Y
7.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
CAD 0.44
Assets
CAD 36.6M
Cash
CAD 9.1M
Current Assets
CAD 23M
Current Liabilities
CAD 3.1M
Debt
CAD 6.9M
Debt Equity
CAD 0.26
Debt FCF
CAD -1.62
Equity
CAD 26.6M
Interest Coverage
-3.71
Liabilities
CAD 10M
Long Term Assets
CAD 13.5M
Long Term Liabilities
CAD 6.9M
Net Cash
CAD 2.2M
Net Cash By Market Cap
CAD 6.46
Net Cash Growth
-66.23%
Net Debt Equity
CAD -0.08
Tangible Book Value
CAD 23M
Tangible Book Value Per Share
CAD 0.17
WACC
7.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
7.51
Inventory Turnover
1.09
Net Working Capital
CAD 11.1M
Quick ratio
4.26
Working Capital
CAD 20M
Working Capital Turnover
CAD 0.8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-1.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-5.66%
1Y total return
-34.21%
200-day SMA
0.25
3Y total return
-34.21%
50-day SMA
0.24
50-day SMA vs 200-day SMA
50under200
5Y total return
-58.33%
All Time High
1.9
All Time High Change
-86.84%
All Time High Date
2000-03-06
All Time Low
0.12
All Time Low Change
108.33%
All Time Low Date
2013-07-24
ATR
0.01
Beta
0.54
Beta1y
-0.27
Beta2y
-0.26
Ch YTD
8.7
High
0.25
High52
0.4
High52 Date
2025-05-08
High52ch
-37.5%
Low
0.25
Low52
0.21
Low52 Date
2026-01-21
Low52ch
19.05%
Ma50ch
3.01%
Price vs 200-day SMA
1.79%
RSI
53.04
RSI Monthly
42.67
RSI Weekly
51.6
Sharpe ratio
-0.5x
Sortino ratio
-0.6
Total Return
-1.38%
Tr YTD
8.7
Tr15y
-28.57%
Tr1m
11.11%
Tr1w
-1.96%
Tr3m
11.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
CAD -3.6M
Operating margin
-21.49

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

8
MetricValue
Float
115,386,804%
Net Borrowing
-1,054,214
Shares Insiders
16.4%
Shares Out
138,024,647
Shares Qo Q
2.08%
Shares Yo Y
1.38%
Short Float
0.01%
Short Shares
0.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

56
MetricValue
Adjusted FCF
CAD -4.9M
Average Volume
59,884.05x
Bv Per Share
0.19
CAPEX
CAD -764,611
Ch10y
-5.66
Ch15y
-28.57
Ch1m
11.11
Ch1w
-1.96
Ch1y
-34.21
Ch20y
-66.22
Ch3m
11.11
Ch3y
-34.21
Ch5y
-58.33
Ch6m
2.04
Change
0%
Change From Open
0
Close
0.25
Days Gap
0
Depreciation Amortization
1,358,025
Dollar Volume
6,750
Earnings Date
2026-05-14
EBIT
CAD -3.6M
EBITDA
CAD -2.2M
EPS
CAD -0.03
F Score
3
FCF
CAD -4.2M
FCF EV Yield
-13.14x
FCF Per Share
CAD -0.03
Financing CF
289,540
Fiscal Year End
September
Founded
1,988
Income Tax
CAD -55,726
Investing CF
-764,611
Is Primary Listing
1
Last Earnings Date
2026-02-12
Last Report Date
2025-12-31
Ma150
0.24
Ma150ch
3.73%
Ma20
0.25
Ma20ch
0.89%
Net CF
-3,950,462
Next Earnings Date
2026-05-14
Open
0.25
Position In Range
0
Ppne
9,940,472
Price Date
2026-05-08
Ptbv Ratio
1.5
Relative Volume
0.45x
Revenue
16,760,273x
SBC By Revenue
3.78x
Share Based Comp
633,297
Tax By Revenue
-0.33x
Tr20y
-66.22%
Tr6m
2.04%
Volume
27,000
Z Score
2.1
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TSX/MBX pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/MBX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-34.2%
S&P 500 1Y: n/a
3Y total return
-34.2%
S&P 500 3Y: n/a
5Y total return
-58.3%
S&P 500 5Y: n/a
10Y total return
-5.7%
S&P 500 10Y: n/a
Ownership

Who owns TSX/MBX?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+16.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+0.0%
Float sold short by bearish positioning
Y/Y dilution
+1.4%
Negative means the company is buying back shares.
Technical

TSX/MBX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
53.0
Neutral momentum band
Price vs 200-day MA
+1.8%
50/200-day relationship not available
Beta (5Y)
0.54
Less volatile than the market
Sharpe ratio
-0.50
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TSX/MBX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/MBX stock rating?

tsx/MBX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/MBX analysis?

The full report lives at /stocks/tsx/MBX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/MBX?

The latest report frames tsx/MBX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/MBX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.